Replies to post #161889 on Biotech Values

[genisi]

KMDA

Hard for me to handicap what a fair value is for this company since their drug targets and indications are perhaps a bit atypical

FWIW, I'd say their current business is worth about $150M. They have a few 'sure' things in their pipeline like the Rabies IgG product that brings about $50M more to the value. Inhaled AAT, if successful would of course boost their value by far.

[genisi]

KMDA - AAT in type 1 diabetes (extension study of the phase 1/2 trial)

http://maya.tase.co.il/bursa/report.asp?report_cd=852638-00&CompCd=1267&Type=Pdf